Kathryn Guarini
Director · 2 filings · Latest: Sep 2, 2026
REGENERON PHARMACEUTICALS, INC.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
REGN | Kathryn Guarini | Director | Sep 2, 2026 | Sale | $850.00 | 400 | $340.0K | 603 | |
REGN | Kathryn Guarini | Director | Sep 2, 2026 | Option Exercise | $719.37 | 400 | $287.7K | 1,003 | |
REGN | Guarini Kathryn | — | Sep 2, 2026 | Proposed Sale | $850.00 | 400 | $340.0K | — | |
REGN | Kathryn Guarini | Director | Aug 10, 2026 | Sale | $800.00 | 400 | $320.0K | 603 | |
REGN | Kathryn Guarini | Director | Aug 10, 2026 | Option Exercise | $719.37 | 400 | $287.7K | 1,003 | |
REGN | Guarini Kathryn | — | Aug 10, 2026 | Proposed Sale | $800.00 | 400 | $320.0K | — |